Published in Antimicrob Agents Chemother on June 01, 1979
In vitro evaluation of cefoperazone. Antimicrob Agents Chemother (1980) 2.22
Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother (1986) 1.95
Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin Microbiol Rev (1992) 1.84
Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother (1986) 1.32
pH-dependent oxacillin tolerance of Staphylococcus aureus. Antimicrob Agents Chemother (1983) 1.19
Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics. Antimicrob Agents Chemother (1986) 1.10
Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrob Agents Chemother (1983) 1.06
Tolerance percentage as a criterion for the detection of tolerant Staphylococcus aureus strains. Antimicrob Agents Chemother (1984) 0.99
Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis. Antimicrob Agents Chemother (1981) 0.97
Lack of reproducibility of macrodilution MBCs for Staphylococcus aureus. Antimicrob Agents Chemother (1984) 0.94
Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice. Antimicrob Agents Chemother (1984) 0.93
Oscillating tolerance in synchronized cultures of Staphylococcus aureus. Antimicrob Agents Chemother (1985) 0.93
Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis. Antimicrob Agents Chemother (1983) 0.88
Screening of Neisseria gonorrhoeae for tolerant response to beta-lactam antibiotics. Antimicrob Agents Chemother (1981) 0.88
Macrodilution MBC result reproducibility for methicillin-susceptible and reputedly tolerant Staphylococcus aureus isolates. Antimicrob Agents Chemother (1988) 0.76
Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome. Ann Clin Microbiol Antimicrob (2011) 0.75
Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol (1966) 27.11
A new type of penicillin resistance of Staphylococcus aureus. Lancet (1977) 9.15
Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature (1970) 9.07
Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicin. Antimicrob Agents Chemother (1976) 6.26
Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1978) 4.46
Susceptibility of clinical isolates of Staphylococcus aureus to killing by oxacillin. Can J Microbiol (1975) 4.37
Medium-dependent variation in bactericidal activity of antibiotics against susceptible Staphylococcus aureus. Antimicrob Agents Chemother (1978) 4.28
Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. Br J Exp Pathol (1973) 3.79
Antibiotic-tolerant Staphylococcus aureus. J Antimicrob Chemother (1978) 3.76
Evidence for participation of autolysins in bactericidal action of oxacillin on Staphylococcus aureus. Antimicrob Agents Chemother (1974) 3.52
Penicillinase production and intrinsic resistance to penicillins in Staphylococcus aures. Lancet (1966) 3.34
PERSISTENCE OF STAPHYLOCOCCUS AUREUS IN PENICILLIN IN VITRO. J Gen Microbiol (1964) 2.43
Some salient features of Staphylococcus aureus endocarditis. Am J Med (1973) 2.17
Treatment of bacterial endocarditis. N Engl J Med (1954) 2.01
Isolation and characterization of a mutant of Staphylococcus aureus deficient in autolytic activity. J Bacteriol (1976) 1.97
Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci (1971) 1.36
Persistent bacteremia in staphylococcal endocarditis. Am J Med (1978) 1.07
A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med (1966) 5.80
Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest (1973) 5.49
Is the establishment defensible? N Engl J Med (1983) 4.70
Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. Br J Exp Pathol (1973) 3.79
Methods and significance of in vitro testing of bacterial sensitivity to drugs. Am J Med (1965) 3.50
Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72. Medicine (Baltimore) (1977) 3.05
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest (1975) 3.03
The doctors' dilemma. N Engl J Med (1978) 2.78
Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980. Medicine (Baltimore) (1982) 2.74
The generalist imperative. Hosp Pract (Off Ed) (1993) 2.61
Project 3000 by 2000. Racial and ethnic diversity in U.S. medical schools. N Engl J Med (1994) 2.37
Significance of bacterial variants in urine of patients with chronic bacteriuria. J Clin Invest (1965) 2.18
Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. J Clin Invest (1974) 1.96
Medical students and primary care. What makes specialties so special? JAMA (1994) 1.77
Antimicrobial prophylaxis of bacterial endocarditis. Prudent caution or bacterial overkill? Am J Med (1978) 1.58
Ampicillin in the treatment of enterococcal endocarditis. Ann Intern Med (1966) 1.58
Pathogenesis of meningitis. VIII. Cerebrospinal fluid and blood concentrations of methicillin, cephalothin, and cephaloridine in experimental pneumococcal meningitis. J Lab Clin Med (1969) 1.54
Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis. J Lab Clin Med (1967) 1.53
Chemotherapy of experimental streptococcal endocarditis. V. Effect of duration of infection and retained intracardiac catheter on response to treatment. J Lab Clin Med (1976) 1.51
Progress report on hospital cost control in California. More regulation than competition. N Engl J Med (1983) 1.49
Studies on the epidemiology of Escherichia coli infections. V. Factors influencing acquisition of specific serologic groups. J Clin Invest (1967) 1.48
The pathogenesis of fraud in medical science. Ann Intern Med (1986) 1.45
Editorial: Internal medicine 1976: consequences of subspecialization and technology. Ann Intern Med (1976) 1.45
Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis. Infect Immun (1978) 1.44
Relapse and reinfection in chronic bacteriuria. II. The correlation between site of infection and pattern of recurrence in chronic bacteriuria. N Engl J Med (1968) 1.40
Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis. J Lab Clin Med (1977) 1.31
The evolution of departments of medicine. N Engl J Med (1980) 1.30
The kappa-deleting element. Germline and rearranged, duplicated and dispersed forms. J Exp Med (1988) 1.23
Internal medicine and family practice. Controversies, conflict and compromise. N Engl J Med (1975) 1.22
Academic medicine: no longer threadbare or genteel. N Engl J Med (1981) 1.18
Fever of unknown origin. An old friend revisited. Arch Intern Med (1992) 1.18
Corticosteroids and infectious diseases. Med Clin North Am (1973) 1.17
Relapse and reinfection in chronic bacteriuria. N Engl J Med (1966) 1.17
Whither infectious diseases? Memories, manpower, and money. J Infect Dis (1986) 1.12
The role of penicillin-induced bacterial variants in experimental pyelonephritis. J Exp Med (1967) 1.10
Defining the good doctor. JAMA (1993) 1.07
Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis (1980) 1.04
Health manpower: numbers, distribution, quality. Ann Intern Med (1975) 1.03
Reimbursement for health care. Training, cost containment, and practice: effect on infectious diseases. Rev Infect Dis (1986) 1.01
Studies on the epidemiology of Escherichia coli, 1960-1968. J Infect Dis (1969) 0.96
Issues in primary care: the academic perspective. J Med Educ (1975) 0.93
Ampicillin. Med Clin North Am (1970) 0.92
'The wheel within a wheel': meningococcal trends. JAMA (1980) 0.92
Changes in the natural history of bacterial endocarditis. J Chronic Dis (1979) 0.91
Urinary tract infections. Postgrad Med (1971) 0.91
Activity of broad-spectrum antibiotics against enterococci and their efficacy in enterococcal endocarditis. Ann N Y Acad Sci (1967) 0.91
Three easy pieces. Acad Med (1990) 0.91
Current and future directions for hospital and physician reimbursement. Effect on the academic medical center. JAMA (1985) 0.90
Kanamycin in urinary tract infections. Ann N Y Acad Sci (1966) 0.90
An informal appraisal of the current status of 'medical sociology'. JAMA (1981) 0.89
Departments of medicine--1973. N Engl J Med (1974) 0.89
Penicillin prophylaxis of experimental S. viridans endocarditis. Trans Assoc Am Physicians (1972) 0.88
Susceptibility of Enterobacteriaceae to nitrofurantoin correlated with eradication of bacteriuria. Antimicrob Agents Chemother (Bethesda) (1966) 0.88
A report on the establishment. J Med Educ (1987) 0.88
Fever of unknown origin. Ann Intern Med (1969) 0.87
Effect of inhibitors of protein synthesis on pyrogen production by granulocytes. Proc Soc Exp Biol Med (1967) 0.87
The four horsemen of the apocalypse. Study of academic medical center governance. JAMA (1982) 0.86
Education in ambulatory care--financing is one piece of the puzzle. N Engl J Med (1989) 0.86
The lady on the track. Acad Med (1991) 0.86
Further evidence for epidemiological virulence of Escherichia coli. Antimicrob Agents Chemother (Bethesda) (1965) 0.85
Studies on the pathogenesis of meningitis. VII. Glucose transport and spinal fluid production in experimental pneumococcal meningitis. J Lab Clin Med (1968) 0.85
Effects of steroids on cerebral electrical activity. Epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit. Arch Neurol (1966) 0.84
Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis. Antimicrob Agents Chemother (1978) 0.82
Immune complexes in infective endocarditis. N Engl J Med (1976) 0.82
Presentation of the Kober Medal for 1973 to Paul B. Beeson. Trans Assoc Am Physicians (1973) 0.81
The roles and responsibilities of United States medical schools in international medical education. Acad Med (1989) 0.81
Medical schools and the public interest: a conversation with Robert G. Petersdorf. Interview by John K. Iglehart. Health Aff (Millwood) (1988) 0.80
Back to the future for internal medicine? Am J Med (1998) 0.79
Evoked bulbar reticular unit activity following delta fiber stimulation of peripheral somatosensory nerve in cat. Exp Neurol (1972) 0.79
Evaluation of the general internist. Arch Intern Med (1977) 0.79
Some thoughts on medical center governance. Pharos Alpha Omega Alpha Honor Med Soc (1987) 0.78
The role of antibiotics, vasoactive drugs and steroids in Gram-negative bacteremia. Ann N Y Acad Sci (1967) 0.78
Primary care applicants--they get no respect. N Engl J Med (1992) 0.78
Retraction of two articles: Myocardial infarct size. J Am Coll Cardiol (1985) 0.78
FUO revisited. Trans Am Clin Climatol Assoc (1983) 0.77
Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis. Antimicrob Agents Chemother (Bethesda) (1965) 0.77
If I were dean. J Am Board Fam Pract (1990) 0.77
Some perturbations in medicine. An interview with Robert G. Petersdorf, MD. JAMA (1982) 0.77
The medical specialist as a primary care provider. Mt Sinai J Med (1978) 0.76
Reversing the decline in internal medicine. Trans Am Clin Climatol Assoc (1994) 0.76
The new procedure for evaluating the clinical competence of candidates to be certified by the American Board of Internal Medicine. Ann Intern Med (1972) 0.76
Is declining class size related to the shortage of family medicine practitioners? Acad Med (1993) 0.75
Editorials: Combination antimicrobial therapy. West J Med (1975) 0.75
Projections for the generalist physician workforce. JAMA (1995) 0.75
Escherichia coli epidemiology, 1960-1968. Trans Am Clin Climatol Assoc (1969) 0.75
The new penicillins and their proper use. Ann Intern Med (1966) 0.75
What is balance in the physician workforce? JAMA (1995) 0.75
Antimicrobial prophylaxis in kidney disease. Postgrad Med (1972) 0.75
How long, oh how long? Am J Med (1997) 0.75
Too many specialists or too few generalists? Health Aff (Millwood) (1993) 0.75
Sodium ampicillin given parenterally. Arch Intern Med (1966) 0.75
The American Ophthalmological Society guest lecture. Some issues in graduate medical education. Trans Am Ophthalmol Soc (1990) 0.75
The 1976 Paul B. Beeson lecture. Some observations on experimental endocarditis. Yale J Biol Med (1977) 0.75
Uniform appointment procedure for residents in internal medicine. Arch Intern Med (1968) 0.75
The fables and foibles of academe. Am J Otolaryngol (1985) 0.75
FUO: how it has changed in 20 years. Hosp Pract (Off Ed) (1985) 0.75
A proposal for financing graduate medical education. N Engl J Med (1985) 0.75